COVID‐19 presenting with immune thrombocytopenia: a case report and review of the literature A Murt, AE Eskazan, U Yılmaz, T Ozkan, MC Ar Journal of medical virology 93 (1), 43, 2021 | 67 | 2021 |
Extended half-life coagulation factors: a new era in the management of hemophilia patients MC Ar, C Balkan, K Kavaklı Turkish Journal of Hematology 36 (3), 141, 2019 | 45 | 2019 |
Methods for individualising factor VIII dosing in prophylaxis MC Ar, I Vaide, E Berntorp, S Björkman European Journal of Haematology 93, 16-20, 2014 | 42 | 2014 |
Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion AE Eskazan, D Eyice, EA Kurt, T Elverdi, FF Yalniz, A Salihoglu, MC Ar, ... Leukemia Research 38 (7), 781-787, 2014 | 41 | 2014 |
The impact of obesity and insulin resistance on iron and red blood cell parameters: a single center, cross-sectional study E Altunoğlu, C Müderrisoğlu, F Erdenen, E Ülgen, MC Ar | 39 | 2014 |
Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data … S Ongoren, AE Eskazan, V Suzan, S Savci, I Erdogan Ozunal, S Berk, ... Hematology 23 (4), 212-220, 2018 | 35 | 2018 |
First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate. AE Eskazan, M Ayer, B Kantarcioglu, D Arica, N Demirel, D Aydin, ... British Journal of Haematology 167 (1), 2014 | 30 | 2014 |
Successful management of cryoglobulinemia-induced leukocytoclastic vasculitis with thalidomide in a patient with multiple myeloma M Cem Ar, T Soysal, G Hatemi, A Salihoglu, H Yazici, B Ulku Annals of hematology 84, 609-613, 2005 | 30 | 2005 |
Severe bone marrow failure due to valganciclovir overdose after renal transplantation from cadaveric donors: four consecutive cases MC Ar, M Ozbalak, N Tuzuner, H Bekoz, O Ozer, K Ugurlu, F Tabak, ... Transplantation proceedings 41 (5), 1648-1653, 2009 | 29 | 2009 |
Outcomes of chronic myeloid leukemia patients with early molecular response at 3 and 6 months: a comparative analysis of generic imatinib and glivec AE Eskazan, S Sadri, D Keskin, M Ayer, B Kantarcioglu, N Demirel, ... Clinical Lymphoma Myeloma and Leukemia 17 (12), 804-811, 2017 | 28 | 2017 |
The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia AE Eskazan, T Elverdi, FF Yalniz, A Salihoglu, MC Ar, S Ongoren Aydin, ... Leukemia & Lymphoma 55 (12), 2935-2937, 2014 | 27 | 2014 |
How to treat myelodysplastic syndrome with clinical features resembling Behçet syndrome: a case-based systematic review U Yilmaz, MC Ar, SN Esatoglu, I Bavunoglu, YZ Erzin, AI Hatemi, ... Annals of hematology 99, 1193-1203, 2020 | 26 | 2020 |
Personalized prophylaxis in people with hemophilia A: challenges and achievements MC Ar, Z Baslar, T Soysal Expert Review of Hematology 9 (12), 1203-1208, 2016 | 26 | 2016 |
Secondary infections in febrile neutropenia in hematological malignancies: more than another febrile neutropenic episode A Demirel, F Tabak, MC Ar, B Mete, Ş Öngören, M Yemişen, R Özaras, ... Turkish Journal of Hematology 32 (3), 243, 2015 | 25 | 2015 |
Generics in chronic myeloid leukemia: current arguments for and against and the established evidence T Soysal, AE Eskazan, MC Ar Expert Review of Hematology 7 (6), 697-699, 2014 | 25 | 2014 |
Intracranial extramedullary hematopoiesis in patients with thalassemia: a case report and review of the literature AE Eskazan, MC Ar, Z Baslar Transfusion 52 (8), 1715-1720, 2012 | 25 | 2012 |
Polycythemia vera: diagnosis, clinical course, and current management Y Büyükaşik, R Ali, MC Ar, M Turgut, AS YAVUZ, G Saydam Turkish journal of medical sciences 48 (4), 698-710, 2018 | 24 | 2018 |
Portal hypertension and myeloproliferative neoplasms: a relationship revealed AB Toros, S Gokcay, G Cetin, MC Ar, Y Karagoz, B Kesici International Scholarly Research Notices 2013 (1), 673781, 2013 | 24 | 2013 |
An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality R Kara Ali, S Surme, II Balkan, A Salihoglu, M Sahin Ozdemir, Y Ozdemir, ... Annals of hematology 99, 1925-1932, 2020 | 23 | 2020 |
Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis G Cetin, T Ozkan, S Turgut, M Ali Cikrikcioglu, M Cem Ar, M Ayer, A Unlu, ... Molecular biology reports 41, 6737-6742, 2014 | 22 | 2014 |